a month ago
VKTX
AnalystsAnnabel SamimyAnnabel Samimy's Stock Forecasts
AnalystsAnnabel Samimy
Analyst Ranking
Top 5%
#206 out of 4563 analysts
Average Return
+43.92%
Win Rate
52%23 out of 44
Risk vs Reward
Poor
Good
Annabel Samimy's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Viking Therapeutics IncVKTX | +439.77% | $15.44 | $83.34 | 2023-03-28 - 2024-03-27 | Strong Buy |
Viking Therapeutics IncVKTX | +428.83% | $11.83 | $62.56 | 2023-03-17 - 2024-03-15 | Strong Buy |
Viking Therapeutics IncVKTX | +357.59% | $14.22 | $65.07 | 2023-08-08 - 2024-04-24 | Strong Buy |
Prometheus Biosciences IncRXDX | +276.85% | $51.35 | $193.51 | 2022-11-01 - 2023-04-17 | Strong Buy |
Durect CorpDRRX | +170.13% | $7.70 | $20.80 | 2014-10-28 - 2015-10-28 | Strong Buy |
Annabel Samimy Analyst Color
Get additional color on Annabel Samimy's coverage of popular stocks
a month ago
JAZZ
2 months ago
EOLS
2 months ago
VKTX
8 months ago
APLS
a year ago
VKTX
a year ago
RXDX
a year ago
RETA
a year ago
VKTX
Annabel Samimy's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Regenxbio IncRGNX | 2 | Strong Buy | $40.00 | +149.38% | Maintains | 13 days ago |
Viking Therapeutics IncVKTX | 6 | Strong Buy | $80.00 | +22.94% | Reiterates | a month ago |
Jazz Pharmaceuticals PLCJAZZ | 3 | Strong Buy | $230.00 | +112.33% | Maintains | a month ago |
Evolus IncEOLS | 1 | Strong Buy | $25.00 | +117.39% | Reiterates | 2 months ago |
Inventiva SaIVA | 2 | Strong Buy | $25.00 | +671.60% | Maintains | 2 months ago |
Oculis Holding AgOCS | 1 | Strong Buy | $35.00 | +192.15% | Initiates Coverage On | 7 months ago |
Apellis Pharmaceuticals IncAPLS | 3 | Strong Buy | $65.00 | +30.18% | Maintains | 8 months ago |
Reata Pharmaceuticals IncRETA | 2 | Hold | $172.50 | +0.08% | Downgrades | 9 months ago |
Cara Therapeutics IncCARA | 2 | Strong Buy | $28.00 | +4,066.67% | Reiterates | 10 months ago |
Fibrogen IncFGEN | 2 | Hold | $11.00 | +1,017.89% | Downgrades | 10 months ago |
Prometheus Biosciences IncRXDX | 2 | Hold | $200.00 | N/A | Downgrades | a year ago |
Mineralys Therapeutics IncMLYS | 1 | Strong Buy | $45.00 | N/A | Initiates Coverage On | a year ago |
Horizon Therapeutics Public Ltd CoHZNP | 4 | Hold | $116.50 | N/A | Downgrades | a year ago |
Clearside Biomedical IncCLSD | 1 | Strong Buy | $8.00 | N/A | Upgrades | a year ago |
Evofem Biosciences IncEVFM | 2 | Hold | $0.50 | N/A | Downgrades | 2 years ago |
Iveric Bio IncISEE | 2 | Strong Buy | $35.00 | N/A | Maintains | 2 years ago |
Aerie Pharmaceuticals IncAERI | 2 | Hold | $15.25 | N/A | Downgrades | 2 years ago |
Elicio Therapeutics IncELTX | 3 | Hold | $15.00 | N/A | Downgrades | 2 years ago |
Rani Therapeutics Holdings IncRANI | 1 | Strong Buy | $24.00 | N/A | Initiates Coverage On | 3 years ago |
Calliditas Therapeutics AbCALT | 1 | Strong Buy | $28.00 | N/A | Initiates Coverage On | 4 years ago |
Radius Health IncRDUS1 | 1 | Hold | $20.00 | N/A | Initiates Coverage On | 4 years ago |
Therapeuticsmd IncTXMD | 3 | Strong Buy | $750.00 | N/A | Maintains | 4 years ago |
Supernus Pharmaceuticals IncSUPN | 4 | Hold | $24.00 | N/A | Maintains | 4 years ago |
Revance Therapeutics IncRVNC | 1 | Strong Buy | $31.00 | N/A | Maintains | 4 years ago |
Durect CorpDRRX | 4 | Hold | $21.00 | N/A | Maintains | 5 years ago |
Zogenix IncZGNX | 2 | Strong Buy | $61.00 | N/A | Maintains | 5 years ago |
Endo International PLCENDPQ | 2 | Hold | $17.00 | N/A | Maintains | 6 years ago |
Innocoll Holdings PLCINNL | 1 | Hold | N/A | N/A | Downgrades | 7 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.